Perspective Therapeutics
CATX
CATX
127 hedge funds and large institutions have $655M invested in Perspective Therapeutics in 2024 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 48 increasing their positions, 23 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
21% more funds holding
Funds holding: 105 → 127 (+22)
15.5% more ownership
Funds ownership: 57.32% → 72.82% (+16%)
98% less call options, than puts
Call options by funds: $25K | Put options by funds: $1.37M
Holders
127
Holding in Top 10
2
Calls
$25K
Puts
$1.37M
Top Buyers
| 1 | +$71.7M | |
| 2 | +$15.9M | |
| 3 | +$13.7M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.84M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$7.6M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$7.52M | |
| 3 | -$6.6M | |
| 4 |
O
OrbiMed
New York
|
-$4.91M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.64M |